Evidence map›Paper›PMID 26209625›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.

Jessica Mayeux, Brian Skaug, Wei Luo, Lisa M Russell, Shinu John, Prontip Saelee, Hansaa Abbasi, Quan-Zhen Li, Lee Ann Garrett-Sinha, Anne B Satterthwaite

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Immunogenetics of Lupus Erythematosus.Advances in experimental medicine and biology · 2022
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jessica MayeuxDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Brian SkaugDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Wei LuoDepartment of Biochemistry, Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, NY 14203; and.
Lisa M RussellDepartment of Biochemistry, Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, NY 14203; and.
Shinu JohnDepartment of Biochemistry, Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, NY 14203; and.
Prontip SaeleeDepartment of Biochemistry, Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, NY 14203; and.
Hansaa AbbasiDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Quan-Zhen LiDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Lee Ann Garrett-SinhaDepartment of Biochemistry, Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, NY 14203; and anne.satterthwaite@utsouthwestern.edu leesinha@buffalo.edu.
Anne B SatterthwaiteDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390 anne.satterthwaite@utsouthwestern.edu leesinha@buffalo.edu.
The University of Texas Southwestern Medical Center · USUniversity at Buffalo, State University of New York · US

Funding

INTEGRATIVE IMMUNOLOGY TRAINING PROGRAMT32AI005284 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Nan Yan · 2003 to 2026
$7.4M
Identification of Specific Roles for Ets-1 in B Cell ToleranceR01AI085127 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI GARRETT-SINHA, LEE ANN · 2010 to 2014
$2.1M
Functional Relationships Between the Lupus Susceptibility Loci Lyn and Ets1R21AI099422 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SATTERTHWAITE, ANNE B · 2012 to 2013
$323k
NIAID NIH HHS AI005284NIAID NIH HHS AI085127NIAID NIH HHS AI099422NIAID NIH HHS R01 AI085127NIAID NIH HHS R21 AI099422NIAID NIH HHS T32 AI005284
6 · The paper itself

Abstract

Tight control of B cell differentiation into plasma cells (PCs) is critical for proper immune responses and the prevention of autoimmunity. The Ets1 transcription factor acts in B cells to prevent PC differentiation. Ets1(-/-) mice accumulate PCs and produce autoantibodies. Ets1 expression is downregulated upon B cell activation through the BCR and TLRs and is maintained by the inhibitory signaling pathway mediated by Lyn, CD22 and SiglecG, and SHP-1. In the absence of these inhibitory components, Ets1 levels are reduced in B cells in a Btk-dependent manner. This leads to increased PCs, autoantibodies, and an autoimmune phenotype similar to that of Ets1(-/-) mice. Defects in inhibitory signaling molecules, including Lyn and Ets1, are associated with human lupus, although the effects are more subtle than the complete deficiency that occurs in knockout mice. In this study, we explore the effect of partial disruption of the Lyn/Ets1 pathway on B cell tolerance and find that Lyn(+/-)Ets1(+/-) mice demonstrate greater and earlier production of IgM, but not IgG, autoantibodies compared with Lyn(+/-) or Ets1(+/-) mice. We also show that Btk-dependent downregulation of Ets1 is important for normal PC homeostasis when inhibitory signaling is intact. Ets1 deficiency restores the decrease in steady state PCs and Ab levels observed in Btk(-/-) mice. Thus, depending on the balance of activating and inhibitory signals to Ets1, there is a continuum of effects on autoantibody production and PC maintenance. This ranges from full-blown autoimmunity with complete loss of Ets1-maintaining signals to reduced PC and Ab levels with impaired Ets1 downregulation.

Indexed as

Agammaglobulinaemia Tyrosine KinaseAnimalsAntibodiesAutoantibodiesBlotting, WesternB-LymphocytesCell DifferentiationEnzyme-Linked Immunosorbent AssayEpistasis, GeneticFlow CytometryGene ExpressionImmunoglobulin MMice, Inbred C57BLMice, KnockoutPlasma CellsProtein-Tyrosine KinasesAgammaglobulinaemia Tyrosine KinaseAntibodiesAutoantibodiesBTK protein, humanEts1 protein, mouseImmunoglobulin Mlyn protein-tyrosine kinaseProtein-Tyrosine KinasesProto-Oncogene Protein c-ets-1src-Family Kinases

Identifiers

PMID26209625
PMCPMC4546901
OpenAlexW1804456496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.